VOR
Vor Biopharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
VOR Filings
Filing Date
Form Description
Form Type
2025-12-01
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-01 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-18
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-18 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-14 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-13
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-13 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-12
Form 8-K - Current report
Key Events
2025-11-12 · Key Events
Form 8-K - Current report
2025-11-12
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-12 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-10
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-10 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-10
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
2025-11-10 ·
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
2025-11-07
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-07 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-05
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-05 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
